Funding and DSMB Membership in the VICTAS Clinical Trial

Two unusual circumstances arose in the conduct, review, and publication of the VICTAS randomized clinical trial. First, the funder reportedly withdrew financial support for the study after enrollment of only 25% of the planned study sample, resulting in early termination of the study; and second, a member of the data and safety monitoring board (DSMB) is an author of the article.
Source: JAMA - Category: General Medicine Source Type: research